CTOs on the Move

SunLink Health Systems, Inc.

www.sunlinkhealth.com

 
SunLink Health Systems, Inc. currently operates seven community hospitals and related nursing home and home care businesses in the Southeast and Midwest, and its specialty pharmacy business, SunLink Scripts Rx, in Louisiana and Georgia. Each SunLink hospital is the only hospital in its community. SunLink's operating strategy is to link patients' needs with dedicated physicians and health professionals to deliver quality, efficient medical care and healthcare products and services in each area it serves. For additional information on SunLink Health Systems, Inc.
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

MIDWEST OPTICAL SYSTEMS

MIDWEST OPTICAL SYSTEMS is a Palatine, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Billing Management Inc

Medical Billing Management Inc is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Health Plan of Nevada

Health Plan of Nevada offers you an extended network of providers to choose from, ranging from Primary Care to Specialties. For a complete listing, refer to the Provider Directory link to the right.

Talcomp

Talcomp is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Iterative Health

Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD). We use advanced machine learning and computer vision to interpret endoscopic images along with other types of data, helping clinicians to better assess patients with potential GI problems. This gives practitioners enhanced capabilities in the detection, annotation, disease scoring and treatment of GI related diseases. Iterative Health is initially applying these advances towards standardizing disease severity characterization for inflammatory bowel disease. Ultimately, the company aims to establish more meaningful endpoints to serve as better predictors of both therapeutic response and disease outcomes. The company is headquartered in Cambridge, Massachusetts.